Navigation Links
Precision Therapeutics President and CEO Sean McDonald Named Ernst & Young Entrepreneur of the Year(R) 2008 Regional Award Winner
Date:7/2/2008

PITTSBURGH, July 2 /PRNewswire/ -- Precision Therapeutics today announced that its President and Chief Executive Officer Sean McDonald received the Ernst & Young Entrepreneur of the Year(R) 2008 Award in the Applied Science category in the Upstate New York, Western Pennsylvania and West Virginia region. This award recognizes outstanding entrepreneurs who are building and leading dynamic growth businesses. McDonald was selected by an independent panel of judges and the award was presented at an Ernst & Young Entrepreneur of the Year gala event at the Carnegie Music Hall in Pittsburgh on Friday, June 27, 2008.

"Being named an Ernst & Young Entrepreneur of the Year is a great honor for me and my team as we work towards our goal of improving the lives of people living with cancer," said McDonald. "This is not only a win for Precision; it is also a win for the growing life science industry in the Pittsburgh region."

Sean joined Precision Therapeutics in 2001 and serves as President and CEO. Prior to joining Precision, Sean founded Automated Healthcare in 1992, developing the first robotics-based solution to hospital pharmacy management. Automated Healthcare was successfully acquired by McKesson Corporation in 1996. In addition to his current award, Sean has been recognized with a 1999 Ernst & Young Entrepreneur of the Year Award, a 1999 Carnegie Award for Excellence in Science and Technology, the Smithsonian Institution Award for heroic achievement in information technology, and the Pittsburgh Life Sciences Greenhouse 2004 PIONEER award. Sean received a BS in Engineering from the University of Pennsylvania and an MS in Electrical Engineering and Computer Science from the University of Florida.

About Precision Therapeutics

Precision Therapeutics is a diagnostics services company dedicated to providing physicians and patients with actionable clinical information to personalize cancer treatments. Precision's ChemoFx(R) test measures an individual patient's tumor response to a range of therapeutic alternatives under consideration by a physician.

For more information, please visit http://www.precisiontherapeutics.com.

About Ernst & Young's Entrepreneur Of The Year

Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Ernst & Young's Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The award makes a difference through the unique way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Ernst & Young Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

For more information, please visit http://www.ey.com.


'/>"/>
SOURCE Precision Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
2. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
3. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
4. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
5. Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order
6. New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput
7. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
8. Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years
9. 2008 International Federation of Adipose Therapeutics and Science (IFATS) Conference Date Set
10. Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
11. Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... , ... Facial plastic surgeon, Dr. John D. Rachel of Timeless You™ ... to two local organizations: North Chicago Animal Control and Friends and Our House of ... of authorized and trained volunteers who support rescued animals held in the City of ...
(Date:12/7/2016)... ... 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers Delightful ... Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 ... Delightful Deals on Botox® and Juvederm® just in time for the holiday ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas Premier Locksmith ... carried out by unethical locksmith companies and is urging Search Engines to improve ... to Texas Premier Locksmith, these fraudulent locksmith services take advantage of consumers locked ...
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... a 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. ... Awards recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken ...
(Date:12/7/2016)... Studio City, CA (PRWEB) , ... December 07, 2016 , ... ... number during the holidays and winter seasons. One major study analyzing heart attacks ... January compared to August of a given year. We would all agree of course–no ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... LONDON , Dec. 6, 2016  "Blood ... all cancers announced ....." The Diagnostic, Monitoring ... revolution in cancer diagnostics is occurring using in ... a new company with impressive backing, has announced ... The technology is moving faster than the market. ...
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
(Date:12/6/2016)... Eurofins Genomics today announced it has ... American Pathologists (CAP) and certification under the Clinical ... in Louisville, KY , where ... "Our new CLIA-licensed and CAP-accredited clinical ... considered the ,Gold Standard, method for validation of ...
Breaking Medicine Technology: